We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
+10.04%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$37.9B
AUM Growth
Cap. Flow
+$36.1B
Cap. Flow %
95.33%
Top 10 Hldgs %
21.49%
Holding
1,659
New
1,659
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.39B
2
AAPL icon
Apple
AAPL
+$1.38B
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$896M
4
AMZN icon
Amazon
AMZN
+$820M
5
JNJ icon
Johnson & Johnson
JNJ
+$601M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 19.62%
2 Healthcare 15.12%
3 Financials 15.09%
4 Consumer Discretionary 10.34%
5 Industrials 9.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCJ icon
1626
Cameco
CCJ
$38.3B
$156K ﹤0.01%
+17,500
New +$162K
NTRA icon
1627
Natera
NTRA
$37.5B
$156K ﹤0.01%
+4,637
New +$171K
KALV
1628
DELISTED
KalVista Pharmaceuticals
KALV
$151K ﹤0.01%
+8,506
New +$111K
CCXI
1629
DELISTED
ChemoCentryx, Inc.
CCXI
$146K ﹤0.01%
+3,697
New +$64.9K
GDDY icon
1630
GoDaddy
GDDY
$12.3B
$145K ﹤0.01%
+2,133
New +$141K
BOX icon
1631
Box
BOX
$4.02B
$142K ﹤0.01%
+8,436
New +$141K
DNLI icon
1632
Denali Therapeutics
DNLI
$3.67B
$139K ﹤0.01%
+7,976
New +$133K
XFOR icon
1633
X4 Pharmaceuticals
XFOR
$363M
$131K ﹤0.01%
+409
New +$147K
FOLD
1634
DELISTED
Amicus Therapeutics
FOLD
$129K ﹤0.01%
+13,177
New +$121K
NVTA
1635
DELISTED
Invitae Corporation
NVTA
$128K ﹤0.01%
+7,961
New +$141K
BMY.RT
1636
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$124K ﹤0.01%
+41,294
New +$107K
NTNX icon
1637
Nutanix
NTNX
$14.9B
$122K ﹤0.01%
+3,908
New +$115K
CLDR
1638
DELISTED
Cloudera, Inc.
CLDR
$120K ﹤0.01%
+10,301
New +$98.7K
SGMO
1639
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$119K ﹤0.01%
+14,316
New +$132K
ECOM
1640
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$119K ﹤0.01%
+13,148
New +$121K
MIRM icon
1641
Mirum Pharmaceuticals
MIRM
$6.89B
$116K ﹤0.01%
+4,706
New +$50.2K
PGRE
1642
DELISTED
Paramount Group
PGRE
$113K ﹤0.01%
+8,100
New +$109K
DXPE icon
1643
DXP Enterprises
DXPE
$2.62B
$100K ﹤0.01%
+2,500
New +$93.2K
MEOH icon
1644
Methanex
MEOH
$4.32B
$96K ﹤0.01%
+2,479
New +$93K
BB icon
1645
BlackBerry
BB
$5.01B
$94K ﹤0.01%
+14,600
New +$80.1K
AWI icon
1646
Armstrong World Industries
AWI
$6.86B
$80K ﹤0.01%
+850
New +$81.2K
ICL icon
1647
ICL Group
ICL
$6.81B
$79K ﹤0.01%
+16,865
New +$77.9K
CRNX icon
1648
Crinetics Pharmaceuticals
CRNX
$8.86B
$55K ﹤0.01%
+2,208
New +$42K
BPY
1649
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
$49K ﹤0.01%
+2,656
New +$50.2K
ESLT icon
1650
Elbit Systems
ESLT
$38.4B
$47K ﹤0.01%
+300
New +$48.9K

Similar funds

Ensign Peak Advisors's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for Ensign Peak Advisors, which disclosed 1,659 positions worth $37.9B. Its ten largest holdings account for 21% of the portfolio.

Its largest position is Microsoft: 9,487,124 shares worth $1.5B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q4 2019 buy was Microsoft: 9,487,124 shares worth $1.5B.
  • Ensign Peak Advisors's ten largest holdings make up 21% of its $37.9B portfolio in Q4 2019.
  • Ensign Peak Advisors disclosed 1,659 positions in Q4 2019, its first 13F filing on record.

Based on Ensign Peak Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.